WAVE LIFE SCIENCES LTD. Basic Shares Outstanding (Weighted Average)
WAVE LIFE SCIENCES LTD. (WVE) reported Basic Shares Outstanding (Weighted Average) of 204.01 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-07-30
- WAVE LIFE SCIENCES LTD. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 204.01M shares, a 24.40% increase year-over-year.
- WAVE LIFE SCIENCES LTD. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 200.17M shares, a 23.13% increase year-over-year.
- WAVE LIFE SCIENCES LTD. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 180.28M shares, a 11.49% increase year-over-year.
- WAVE LIFE SCIENCES LTD. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 167.74M shares, a 26.54% increase year-over-year.
- WAVE LIFE SCIENCES LTD. weighted average number of shares outstanding, basic for fiscal 2025 was 168.65M shares, a 21.96% increase from fiscal 2024.
- WAVE LIFE SCIENCES LTD. weighted average number of shares outstanding, basic for fiscal 2024 was 138.28M shares, a 30.33% increase from fiscal 2023.
- WAVE LIFE SCIENCES LTD. weighted average number of shares outstanding, basic for fiscal 2023 was 106.10M shares, a 34.55% increase from fiscal 2022.
- WAVE LIFE SCIENCES LTD. weighted average number of shares outstanding, basic for fiscal 2022 was 78.86M shares, a 52.16% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 204.01M shares 10-Q · filed 2026-07-30 | 202.10M shares 10-Q · filed 2026-07-30 | 194.82M shares derived: average of 3 quarters · filed 2026-07-30 | 188.05M shares derived: average of 4 quarters · filed 2026-07-30 | |
| 2026-03-31 | 200.17M shares 10-Q · filed 2026-04-28 | 190.22M shares derived: average of 2 quarters · filed 2026-04-28 | 182.73M shares derived: average of 3 quarters · filed 2026-04-28 | 178.04M shares derived: average of 4 quarters · filed 2026-07-30 | |
| 2025-12-31 | 180.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 174.01M shares derived: average of 2 quarters · filed 2026-02-26 | 170.67M shares derived: average of 3 quarters · filed 2026-07-30 | 168.65M shares 10-K · filed 2026-02-26 | |
| 2025-09-30 | 167.74M shares 10-Q · filed 2025-11-10 | 165.86M shares derived: average of 2 quarters · filed 2026-07-30 | 164.77M shares 10-Q · filed 2025-11-10 | 164.00M shares derived: average of 4 quarters · filed 2026-07-30 | |
| 2025-06-30 | 163.99M shares 10-Q · filed 2026-07-30 | 163.27M shares 10-Q · filed 2026-07-30 | 162.75M shares derived: average of 3 quarters · filed 2026-07-30 | 155.21M shares derived: average of 4 quarters · filed 2026-07-30 | |
| 2025-03-31 | 162.57M shares 10-Q · filed 2026-04-28 | 162.53M shares 10-Q · filed 2025-05-08 | 162.14M shares derived: average of 2 quarters · filed 2026-04-28 | 152.28M shares derived: average of 3 quarters · filed 2026-04-28 | 146.59M shares derived: average of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | 161.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 147.13M shares derived: average of 2 quarters · filed 2026-02-26 | 141.26M shares derived: average of 3 quarters · filed 2026-02-26 | 138.28M shares 10-K · filed 2026-02-26 | |
| 2024-09-30 | 132.56M shares 10-Q · filed 2025-11-10 | 131.05M shares derived: average of 2 quarters · filed 2025-11-10 | 130.47M shares 10-Q · filed 2025-11-10 | 125.54M shares derived: average of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | 129.53M shares 10-Q · filed 2025-07-30 | 129.40M shares 10-Q · filed 2025-07-30 | 123.20M shares derived: average of 3 quarters · filed 2026-02-26 | 118.91M shares derived: average of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | 129.27M shares 10-Q · filed 2025-05-08 | 120.04M shares derived: average of 2 quarters · filed 2026-02-26 | 115.37M shares derived: average of 3 quarters · filed 2026-02-26 | 112.89M shares derived: average of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | 110.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 108.41M shares derived: average of 2 quarters · filed 2026-02-26 | 107.43M shares derived: average of 3 quarters · filed 2026-02-26 | 106.10M shares 10-K · filed 2026-02-26 | |
| 2023-09-30 | 106.03M shares 10-Q · filed 2024-11-12 | 105.74M shares derived: average of 2 quarters · filed 2024-11-12 | 104.53M shares 10-Q · filed 2024-11-12 | 101.93M shares derived: average of 4 quarters · filed 2025-03-04 | |
| 2023-06-30 | 105.46M shares 10-Q · filed 2024-08-08 | 103.77M shares 10-Q · filed 2024-08-08 | 100.56M shares derived: average of 3 quarters · filed 2025-03-04 | 98.89M shares derived: average of 4 quarters · filed 2025-03-04 | |
| 2023-03-31 | 102.06M shares 10-Q · filed 2024-05-10 | 98.11M shares derived: average of 2 quarters · filed 2025-03-04 | 96.71M shares derived: average of 3 quarters · filed 2025-03-04 | 89.15M shares derived: average of 4 quarters · filed 2025-03-04 | |
| 2022-12-31 | 94.16M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | 94.03M shares derived: average of 2 quarters · filed 2025-03-04 | 84.85M shares derived: average of 3 quarters · filed 2025-03-04 | 78.86M shares 10-K · filed 2025-03-04 | |
| 2022-09-30 | 93.90M shares 10-Q · filed 2023-11-09 | 80.19M shares derived: average of 2 quarters · filed 2023-11-09 | 73.75M shares 10-Q · filed 2023-11-09 | 69.54M shares derived: average of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | 66.48M shares 10-Q · filed 2023-08-03 | 63.51M shares 10-Q · filed 2023-08-03 | 61.42M shares derived: average of 3 quarters · filed 2023-08-03 | 58.74M shares derived: average of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | 60.52M shares 10-Q · filed 2023-05-03 | 58.88M shares derived: average of 2 quarters · filed 2023-05-03 | 56.16M shares derived: average of 3 quarters · filed 2023-05-03 | 54.61M shares derived: average of 4 quarters · filed 2023-05-03 | |
| 2021-12-31 | 57.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | 53.98M shares derived: average of 2 quarters · filed 2023-03-23 | 52.64M shares derived: average of 3 quarters · filed 2023-03-23 | 51.83M shares 10-K · filed 2023-03-23 | |
| 2021-09-30 | 50.71M shares 10-Q · filed 2022-11-10 | 50.34M shares derived: average of 2 quarters · filed 2022-11-10 | 50.02M shares 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | 49.97M shares 10-Q · filed 2022-08-11 | 49.22M shares 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |